25.03.2013 Views

Narcissus and Daffodil

Narcissus and Daffodil

Narcissus and Daffodil

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

19 Review of pharmaceutical patents<br />

from the genus <strong>Narcissus</strong><br />

James R. Murray<br />

INTRODUCTION<br />

This chapter is to give the reader a flavour of the richness of concepts associated<br />

with the <strong>Narcissus</strong> genus whilst bowing to the practicalities of reporting complicated<br />

patent processes that evolve over a period of years. No attempt is made to<br />

give definitive lists of published versus granted patents, as such lists would, by<br />

necessity, be out of date by the time of publication of this book. Instead, the<br />

chapter uses the listings of published patents <strong>and</strong> applications as of mid-September<br />

1999 as a basis of a comprehensive review of the areas of research <strong>and</strong> development<br />

of products <strong>and</strong> projects associated with the cultivation <strong>and</strong> utilisation of<br />

narcissus (daffodil) plants <strong>and</strong> their constituents.<br />

On undertaking the search for patents published around the genus <strong>Narcissus</strong>,<br />

28 were identified under the title ‘narcissus’, 11 under ‘daffodil’ <strong>and</strong> 55 under<br />

‘galanthamine’. As galanthamine was originally extracted from the Caucasian<br />

snowdrop it was, perhaps, not surprising that only two of the 39 patents identified<br />

under ‘narcissus’ or ‘daffodil’ referred to galanthamine. Although not strictly<br />

related to <strong>Narcissus</strong> species, these patents are included here for completeness. The<br />

‘narcissus’ <strong>and</strong> ‘daffodil’ titles are mainly related to use in cosmetic agents <strong>and</strong><br />

fragrances, <strong>and</strong> many of these patents are from Japan <strong>and</strong> without equivalents<br />

outside Japan. These patents refer to synthetic molecules designed to mimic narcissus<br />

fragrance, as well as extracts of the plant. The galanthamine patents cover<br />

manufacture, intermediates used in the production of galanthamine, analogues of<br />

galanthamine, <strong>and</strong> the use of the cholinesterase inhibitory <strong>and</strong> nicotinic agonist<br />

pharmacological activities of the compounds in the clinic. Such clinical indications<br />

range from the original Eastern European folklore use of galanthamine in the<br />

management of patients with infantile paralysis (poliomyelitis) to the treatment of<br />

erectile dysfunction!<br />

NARCISSUS AND DAFFODIL PATENTS<br />

Patents related to non-therapeutic uses<br />

A fascinating array of patents describing the utilisation of agents derived from<br />

daffodils, to mimic the fragrance of daffodils, or for agents or methods used to<br />

influence daffodils themselves, was uncovered. Who could fail to be intrigued by<br />

the grappling shovel with twin concave blades mounted on h<strong>and</strong>les, operated with

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!